Roles of microglia in neurodegenerative diseases Microglia are the primary innate immune cells of the CNS, accounting for nearly 10% of CNS cells
It is limited to a maximum of 5 days and carries standard NSAID risks including GI and renal effects
The central reasons (repeatable pattern across literature): Comparator sensitivity: DPP-4i vs sulfonylureas vs SGLT2i changes results Ascertainment differences: Who gets ultrasounds, when, and why Outcome definition: "Thyroid cancer," "tumors," "neoplasm," and "MTC" aren't interchangeable Short follow-up: Better at capturing diagnostic workups than long-term carcinogenesis Residual confounding: Obesity, diabetes duration, smoking, iodine status, healthcare access When Studies Disagree: It's often because they used different comparison drugs, definitions, and populations watched more closely
Very rarely, GLP-1 receptor agonists, including semaglutide, have been associated with cases of pancreatitis
Retatrutide is a triple agonist that targets GLP-1, GIP and glucagon receptors, giving it the broadest receptor profile currently under investigation among incretin peptides